Wegovy cuts heart risks by 20% in large trial todayheadline.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from todayheadline.co Daily Mail and Mail on Sunday newspapers.
TOS Past Presidents Discuss Selected Study Findings miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
<p>New findings show that the medication known as Wegovy® (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past presidents of The Obesity Society and published in <em>The</em> <em>New England Journal of Medicine</em>.</p>